Selected research
Market Outlook & Growth Opportunities
Global Mice Model Genetic Engineering Market Outlook and Growth Opportunities 2026
Market perspective
The global Mice Model Genetic Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Mice Model Genetic Engineering market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Mice Model Genetic Engineering market include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Mice Model Genetic Engineering market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mice Model Genetic Engineering and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mice Model Genetic Engineering revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mice Model Genetic Engineering market.
Mice Model Genetic Engineering Segment by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Mice Model Genetic Engineering status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Mice Model Genetic Engineering key companies, revenue, market share, and recent developments.
3. To split the Mice Model Genetic Engineering breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Mice Model Genetic Engineering market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Mice Model Genetic Engineering significant trends, drivers, influence factors in global and regions.
6. To analyze Mice Model Genetic Engineering competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mice Model Genetic Engineering industry.
Chapter 3: Detailed analysis of Mice Model Genetic Engineering company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Mice Model Genetic Engineering in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Mice Model Genetic Engineering in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Mice Model Genetic Engineering Industry Trends
Table 2. Mice Model Genetic Engineering Industry Drivers
Table 3. Mice Model Genetic Engineering Industry Opportunities and Challenges
Table 4. Mice Model Genetic Engineering Industry Restraints
Table 5. Global Mice Model Genetic Engineering Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Mice Model Genetic Engineering Revenue Share by Company (2021-2026)
Table 7. Global Mice Model Genetic Engineering Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Mice Model Genetic Engineering Key Company Manufacturing Base & Headquarters
Table 9. Global Mice Model Genetic Engineering Company, Product Type & Application
Table 10. Global Mice Model Genetic Engineering Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Mice Model Genetic Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of CRISPR Knockout
Table 15. Significant Companies of CRISPR Knockin
Table 16. Significant Companies of Random Insertions
Table 17. Significant Companies of ES Cell Modification (homologous recombination)
Table 18. Significant Companies of Others
Table 19. Global Mice Model Genetic Engineering Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 20. Global Mice Model Genetic Engineering Sales Value by Type (2021-2026) & (US$ Million)
Table 21. Global Mice Model Genetic Engineering Sales Value by Type (2027-2032) & (US$ Million)
Table 22. Global Mice Model Genetic Engineering Sales Value Share by Type (2021-2026)
Table 23. Global Mice Model Genetic Engineering Sales Value Share by Type (2027-2032)
Table 24. Significant Companies of Pharmaceutical Companies
Table 25. Significant Companies of Biotechnology Companies
Table 26. Significant Companies of Academic & Research Facilities
Table 27. Significant Companies of Contract Research & Manufacturing Organizations
Table 28. Global Mice Model Genetic Engineering Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Mice Model Genetic Engineering Sales Value by Application (2021-2026) & (US$ Million)
Table 30. Global Mice Model Genetic Engineering Sales Value by Application (2027-2032) & (US$ Million)
Table 31. Global Mice Model Genetic Engineering Sales Value Share by Application (2021-2026)
Table 32. Global Mice Model Genetic Engineering Sales Value Share by Application (2027-2032)
Table 33. Global Mice Model Genetic Engineering Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Mice Model Genetic Engineering Sales Value by Region (2021-2026) & (US$ Million)
Table 35. Global Mice Model Genetic Engineering Sales Value Share by Region (2021-2026)
Table 36. Global Mice Model Genetic Engineering Sales Value by Region (2027-2032) & (US$ Million)
Table 37. Global Mice Model Genetic Engineering Sales Value Share by Region (2027-2032)
Table 38. Global Mice Model Genetic Engineering Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 39. Global Mice Model Genetic Engineering Sales Value by Country (2021-2026) & (US$ Million)
Table 40. Global Mice Model Genetic Engineering Sales Value Market Share by Country (2021-2026)
Table 41. Global Mice Model Genetic Engineering Sales Value by Country (2027-2032) & (US$ Million)
Table 42. Global Mice Model Genetic Engineering Sales Value Market Share by Country (2027-2032)
Table 43. B BIOCYTOGEN Company Information
Table 44. B BIOCYTOGEN Business Overview
Table 45. B BIOCYTOGEN Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
Table 47. B BIOCYTOGEN Recent Development
Table 48. Charles River Laboratories Company Information
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
Table 52. Charles River Laboratories Recent Development
Table 53. Cyagen Biosciences Company Information
Table 54. Cyagen Biosciences Business Overview
Table 55. Cyagen Biosciences Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
Table 57. Cyagen Biosciences Recent Development
Table 58. Gempharmatech Company Information
Table 59. Gempharmatech Business Overview
Table 60. Gempharmatech Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. Gempharmatech Mice Model Genetic Engineering Product Portfolio
Table 62. Gempharmatech Recent Development
Table 63. genOway Company Information
Table 64. genOway Business Overview
Table 65. genOway Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. genOway Mice Model Genetic Engineering Product Portfolio
Table 67. genOway Recent Development
Table 68. ingenious targeting laboratory Company Information
Table 69. ingenious targeting laboratory Business Overview
Table 70. ingenious targeting laboratory Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
Table 72. ingenious targeting laboratory Recent Development
Table 73. Ozgene Pty Ltd. Company Information
Table 74. Ozgene Pty Ltd. Business Overview
Table 75. Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
Table 77. Ozgene Pty Ltd. Recent Development
Table 78. Taconic Biosciences, Inc. Company Information
Table 79. Taconic Biosciences, Inc. Business Overview
Table 80. Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
Table 82. Taconic Biosciences, Inc. Recent Development
Table 83. PolyGene AG Company Information
Table 84. PolyGene AG Business Overview
Table 85. PolyGene AG Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. PolyGene AG Mice Model Genetic Engineering Product Portfolio
Table 87. PolyGene AG Recent Development
Table 88. THE JACKSON LABORATORY Company Information
Table 89. THE JACKSON LABORATORY Business Overview
Table 90. THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
Table 92. THE JACKSON LABORATORY Recent Development
Table 93. Yale School of Medicine Company Information
Table 94. Yale School of Medicine Business Overview
Table 95. Yale School of Medicine Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
Table 97. Yale School of Medicine Recent Development
Table 98. University of North Carolina Company Information
Table 99. University of North Carolina Business Overview
Table 100. University of North Carolina Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. University of North Carolina Mice Model Genetic Engineering Product Portfolio
Table 102. University of North Carolina Recent Development
Table 103. University of Nebraska Medical Center Company Information
Table 104. University of Nebraska Medical Center Business Overview
Table 105. University of Nebraska Medical Center Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
Table 107. University of Nebraska Medical Center Recent Development
Table 108. Monash University Company Information
Table 109. Monash University Business Overview
Table 110. Monash University Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Monash University Mice Model Genetic Engineering Product Portfolio
Table 112. Monash University Recent Development
Table 113. UMass Chan Medical School Company Information
Table 114. UMass Chan Medical School Business Overview
Table 115. UMass Chan Medical School Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
Table 117. UMass Chan Medical School Recent Development
Table 118. University of Bonn Company Information
Table 119. University of Bonn Business Overview
Table 120. University of Bonn Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. University of Bonn Mice Model Genetic Engineering Product Portfolio
Table 122. University of Bonn Recent Development
Table 123. Columbia University Company Information
Table 124. Columbia University Business Overview
Table 125. Columbia University Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Columbia University Mice Model Genetic Engineering Product Portfolio
Table 127. Columbia University Recent Development
Table 128. The University of Arizona Company Information
Table 129. The University of Arizona Business Overview
Table 130. The University of Arizona Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. The University of Arizona Mice Model Genetic Engineering Product Portfolio
Table 132. The University of Arizona Recent Development
Table 133. The Weizmann Institute of Science Company Information
Table 134. The Weizmann Institute of Science Business Overview
Table 135. The Weizmann Institute of Science Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
Table 137. The Weizmann Institute of Science Recent Development
Table 138. The Hebrew University of Jerusalem Company Information
Table 139. The Hebrew University of Jerusalem Business Overview
Table 140. The Hebrew University of Jerusalem Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
Table 142. The Hebrew University of Jerusalem Recent Development
Table 143. The Technion – Israel Institute of Technology Company Information
Table 144. The Technion – Israel Institute of Technology Business Overview
Table 145. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
Table 147. The Technion – Israel Institute of Technology Recent Development
Table 148. Hadassah BrainLabs Company Information
Table 149. Hadassah BrainLabs Business Overview
Table 150. Hadassah BrainLabs Mice Model Genetic Engineering Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
Table 152. Hadassah BrainLabs Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Authors List of This Report
Table 155. Secondary Sources
Table 156. Primary Sources
List of Figures
Figure 1. Mice Model Genetic Engineering Product Image
Figure 2. Global Mice Model Genetic Engineering Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 4. Global Mice Model Genetic Engineering Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. CRISPR Knockout Image
Figure 8. CRISPR Knockin Image
Figure 9. Random Insertions Image
Figure 10. ES Cell Modification (homologous recombination) Image
Figure 11. Others Image
Figure 12. Global Mice Model Genetic Engineering Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Mice Model Genetic Engineering Sales Value Share 2021 VS 2025 VS 2032
Figure 14. Global Mice Model Genetic Engineering Sales Value Share by Type (2021-2032)
Figure 15. Pharmaceutical Companies Image
Figure 16. Biotechnology Companies Image
Figure 17. Academic & Research Facilities Image
Figure 18. Contract Research & Manufacturing Organizations Image
Figure 19. Global Mice Model Genetic Engineering Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Mice Model Genetic Engineering Sales Value Share 2021 VS 2025 VS 2032
Figure 21. Global Mice Model Genetic Engineering Sales Value Share by Application (2021-2032)
Figure 22. Global Mice Model Genetic Engineering Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 23. Global Mice Model Genetic Engineering Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 24. North America Mice Model Genetic Engineering Sales Value (2021-2032) & (US$ Million)
Figure 25. North America Mice Model Genetic Engineering Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Europe Mice Model Genetic Engineering Sales Value (2021-2032) & (US$ Million)
Figure 27. Europe Mice Model Genetic Engineering Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Asia-Pacific Mice Model Genetic Engineering Sales Value (2021-2032) & (US$ Million)
Figure 29. Asia-Pacific Mice Model Genetic Engineering Sales Value Share by Country (%), 2025 VS 2032
Figure 30. South America Mice Model Genetic Engineering Sales Value (2021-2032) & (US$ Million)
Figure 31. South America Mice Model Genetic Engineering Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Middle East & Africa Mice Model Genetic Engineering Sales Value (2021-2032) & (US$ Million)
Figure 33. Middle East & Africa Mice Model Genetic Engineering Sales Value Share by Country (%), 2025 VS 2032
Figure 34. USA Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. USA Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. USA Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Canada Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Canada Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Canada Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Mexico Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Mexico Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Mexico Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Germany Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Germany Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Germany Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. France Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. France Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. France Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. U.K. Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. U.K. Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. U.K. Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Italy Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Italy Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Italy Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Spain Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Spain Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Spain Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Russia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Russia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Russia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Netherlands Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Netherlands Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Netherlands Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Nordic Countries Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Nordic Countries Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. China Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. China Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. China Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Japan Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Japan Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Japan Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. South Korea Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. South Korea Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. South Korea Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. India Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. India Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. India Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Australia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Australia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Australia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Southeast Asia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Southeast Asia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Brazil Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Brazil Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Brazil Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Argentina Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Argentina Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Argentina Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Chile Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Chile Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Chile Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Colombia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Colombia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Colombia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Peru Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Peru Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Peru Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Saudi Arabia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Saudi Arabia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Israel Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Israel Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Israel Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. UAE Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. UAE Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. UAE Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Turkey Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Turkey Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Turkey Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Iran Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Iran Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Iran Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Egypt Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Egypt Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Egypt Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Years Considered
Figure 119. Research Process
Figure 120. Key Executives Interviewed
Scope & coverage.
Types
- CRISPR Knockout
- CRISPR Knockin
- Random Insertions
- ES Cell Modification (homologous recombination)
- Others
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Facilities
- Contract Research & Manufacturing Organizations
Companies covered
- B BIOCYTOGEN
- Charles River Laboratories
- Cyagen Biosciences
- Gempharmatech
- genOway
- ingenious targeting laboratory
- Ozgene Pty Ltd.
- Taconic Biosciences, Inc.
- PolyGene AG
- THE JACKSON LABORATORY
- Yale School of Medicine
- University of North Carolina
- University of Nebraska Medical Center
- Monash University
- UMass Chan Medical School
- University of Bonn
- Columbia University
- The University of Arizona
- The Weizmann Institute of Science
- The Hebrew University of Jerusalem
- The Technion – Israel Institute of Technology
- Hadassah BrainLabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mice Model Genetic Engineering Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mice Model Genetic Engineering Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Mice Model Genetic Engineering Market Dynamics
- 2.1 Mice Model Genetic Engineering Industry Trends
- 2.2 Mice Model Genetic Engineering Industry Drivers
- 2.3 Mice Model Genetic Engineering Industry Opportunities and Challenges
- 2.4 Mice Model Genetic Engineering Industry Restraints
3 Mice Model Genetic Engineering Market by Company
- 3.1 Global Mice Model Genetic Engineering Company Revenue Ranking in 2025
- 3.2 Global Mice Model Genetic Engineering Revenue by Company (2021-2026)
- 3.3 Global Mice Model Genetic Engineering Company Ranking (2024-2026)
- 3.4 Global Mice Model Genetic Engineering Company Manufacturing Base and Headquarters
- 3.5 Global Mice Model Genetic Engineering Company Product Type and Application
- 3.6 Global Mice Model Genetic Engineering Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Mice Model Genetic Engineering Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Mice Model Genetic Engineering Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Mice Model Genetic Engineering Market by Type
- 4.1 Mice Model Genetic Engineering Type Introduction
- 4.1.1 CRISPR Knockout
- 4.1.2 CRISPR Knockin
- 4.1.3 Random Insertions
- 4.1.4 ES Cell Modification (homologous recombination)
- 4.1.5 Others
- 4.2 Global Mice Model Genetic Engineering Sales Value by Type
- 4.2.1 Global Mice Model Genetic Engineering Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mice Model Genetic Engineering Sales Value by Type (2021-2032)
- 4.2.3 Global Mice Model Genetic Engineering Sales Value Share by Type (2021-2032)
5 Mice Model Genetic Engineering Market by Application
- 5.1 Mice Model Genetic Engineering Application Introduction
- 5.1.1 Pharmaceutical Companies
- 5.1.2 Biotechnology Companies
- 5.1.3 Academic & Research Facilities
- 5.1.4 Contract Research & Manufacturing Organizations
- 5.2 Global Mice Model Genetic Engineering Sales Value by Application
- 5.2.1 Global Mice Model Genetic Engineering Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mice Model Genetic Engineering Sales Value by Application (2021-2032)
- 5.2.3 Global Mice Model Genetic Engineering Sales Value Share by Application (2021-2032)
6 Mice Model Genetic Engineering Regional Value Analysis
- 6.1 Global Mice Model Genetic Engineering Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mice Model Genetic Engineering Sales Value by Region (2021-2032)
- 6.2.1 Global Mice Model Genetic Engineering Sales Value by Region: 2021-2026
- 6.2.2 Global Mice Model Genetic Engineering Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mice Model Genetic Engineering Sales Value (2021-2032)
- 6.3.2 North America Mice Model Genetic Engineering Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Mice Model Genetic Engineering Sales Value (2021-2032)
- 6.4.2 Europe Mice Model Genetic Engineering Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Mice Model Genetic Engineering Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Mice Model Genetic Engineering Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Mice Model Genetic Engineering Sales Value (2021-2032)
- 6.6.2 South America Mice Model Genetic Engineering Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Mice Model Genetic Engineering Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Mice Model Genetic Engineering Sales Value Share by Country, 2025 VS 2032
7 Mice Model Genetic Engineering Country-level Value Analysis
- 7.1 Global Mice Model Genetic Engineering Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Mice Model Genetic Engineering Sales Value by Country (2021-2032)
- 7.2.1 Global Mice Model Genetic Engineering Sales Value by Country (2021-2026)
- 7.2.2 Global Mice Model Genetic Engineering Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.7.2 France Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.14.2 China Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.17.2 India Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Mice Model Genetic Engineering Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Mice Model Genetic Engineering Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Mice Model Genetic Engineering Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 B BIOCYTOGEN
- 8.1.1 B BIOCYTOGEN Company Information
- 8.1.2 B BIOCYTOGEN Business Overview
- 8.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 8.1.5 B BIOCYTOGEN Recent Developments
- 8.2 Charles River Laboratories
- 8.2.1 Charles River Laboratories Company Information
- 8.2.2 Charles River Laboratories Business Overview
- 8.2.3 Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 8.2.5 Charles River Laboratories Recent Developments
- 8.3 Cyagen Biosciences
- 8.3.1 Cyagen Biosciences Company Information
- 8.3.2 Cyagen Biosciences Business Overview
- 8.3.3 Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 8.3.5 Cyagen Biosciences Recent Developments
- 8.4 Gempharmatech
- 8.4.1 Gempharmatech Company Information
- 8.4.2 Gempharmatech Business Overview
- 8.4.3 Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 8.4.5 Gempharmatech Recent Developments
- 8.5 genOway
- 8.5.1 genOway Company Information
- 8.5.2 genOway Business Overview
- 8.5.3 genOway Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 8.5.5 genOway Recent Developments
- 8.6 ingenious targeting laboratory
- 8.6.1 ingenious targeting laboratory Company Information
- 8.6.2 ingenious targeting laboratory Business Overview
- 8.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 8.6.5 ingenious targeting laboratory Recent Developments
- 8.7 Ozgene Pty Ltd.
- 8.7.1 Ozgene Pty Ltd. Company Information
- 8.7.2 Ozgene Pty Ltd. Business Overview
- 8.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 8.7.5 Ozgene Pty Ltd. Recent Developments
- 8.8 Taconic Biosciences, Inc.
- 8.8.1 Taconic Biosciences, Inc. Company Information
- 8.8.2 Taconic Biosciences, Inc. Business Overview
- 8.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 8.8.5 Taconic Biosciences, Inc. Recent Developments
- 8.9 PolyGene AG
- 8.9.1 PolyGene AG Company Information
- 8.9.2 PolyGene AG Business Overview
- 8.9.3 PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 8.9.5 PolyGene AG Recent Developments
- 8.10 THE JACKSON LABORATORY
- 8.10.1 THE JACKSON LABORATORY Company Information
- 8.10.2 THE JACKSON LABORATORY Business Overview
- 8.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 8.10.5 THE JACKSON LABORATORY Recent Developments
- 8.11 Yale School of Medicine
- 8.11.1 Yale School of Medicine Company Information
- 8.11.2 Yale School of Medicine Business Overview
- 8.11.3 Yale School of Medicine Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 8.11.5 Yale School of Medicine Recent Developments
- 8.12 University of North Carolina
- 8.12.1 University of North Carolina Company Information
- 8.12.2 University of North Carolina Business Overview
- 8.12.3 University of North Carolina Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 8.12.5 University of North Carolina Recent Developments
- 8.13 University of Nebraska Medical Center
- 8.13.1 University of Nebraska Medical Center Company Information
- 8.13.2 University of Nebraska Medical Center Business Overview
- 8.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 8.13.5 University of Nebraska Medical Center Recent Developments
- 8.14 Monash University
- 8.14.1 Monash University Company Information
- 8.14.2 Monash University Business Overview
- 8.14.3 Monash University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 8.14.5 Monash University Recent Developments
- 8.15 UMass Chan Medical School
- 8.15.1 UMass Chan Medical School Company Information
- 8.15.2 UMass Chan Medical School Business Overview
- 8.15.3 UMass Chan Medical School Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 8.15.5 UMass Chan Medical School Recent Developments
- 8.16 University of Bonn
- 8.16.1 University of Bonn Company Information
- 8.16.2 University of Bonn Business Overview
- 8.16.3 University of Bonn Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 8.16.5 University of Bonn Recent Developments
- 8.17 Columbia University
- 8.17.1 Columbia University Company Information
- 8.17.2 Columbia University Business Overview
- 8.17.3 Columbia University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 8.17.5 Columbia University Recent Developments
- 8.18 The University of Arizona
- 8.18.1 The University of Arizona Company Information
- 8.18.2 The University of Arizona Business Overview
- 8.18.3 The University of Arizona Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 8.18.5 The University of Arizona Recent Developments
- 8.19 The Weizmann Institute of Science
- 8.19.1 The Weizmann Institute of Science Company Information
- 8.19.2 The Weizmann Institute of Science Business Overview
- 8.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 8.19.5 The Weizmann Institute of Science Recent Developments
- 8.20 The Hebrew University of Jerusalem
- 8.20.1 The Hebrew University of Jerusalem Company Information
- 8.20.2 The Hebrew University of Jerusalem Business Overview
- 8.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 8.20.5 The Hebrew University of Jerusalem Recent Developments
- 8.21 The Technion – Israel Institute of Technology
- 8.21.1 The Technion – Israel Institute of Technology Company Information
- 8.21.2 The Technion – Israel Institute of Technology Business Overview
- 8.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 8.21.5 The Technion – Israel Institute of Technology Recent Developments
- 8.22 Hadassah BrainLabs
- 8.22.1 Hadassah BrainLabs Company Information
- 8.22.2 Hadassah BrainLabs Business Overview
- 8.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 8.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 8.22.5 Hadassah BrainLabs Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst